• Over a 6-month period in 2007/08 all samples from a blood bank in Alexandria, Egypt (n = 3420) were tested for hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV) antibodies. (who.int)
  • Blood samples were tested for hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), hepatitis C virus (HCV) antibody, HCV RNA, and the aflatoxin-associated 249 ser TP53 mutation. (nih.gov)
  • The blood samples were analyzed (tested) for hepatitis B surface antigen (HBsAg) and anti-HCV antibody using automated Enzyme-Linked Immunosorbent Assay (ELISA). (hindawi.com)
  • A phage with high affinity for hepatitis B surface antigen for the detection of HBsAg. (nih.gov)
  • Therefore, laboratory diagnosis is undertaken using serological and molecular methods to detect HBsAg and specific IgM antibodies recognising core antigen HbcAg. (thenativeantigencompany.com)
  • Hbsag Elisa Laboratories manufactures the hbsag elisa procedure reagents distributed by Genprice. (taq-polymerase-dna.com)
  • The Hbsag Elisa Procedure reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. (taq-polymerase-dna.com)
  • PEDIARIX is approved for use as a 3-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. (nih.gov)
  • Hbsag Assay Laboratories manufactures the hbsag hbc pos hep b core reagents distributed by Genprice. (toll-likereceptors.com)
  • reported an inverse selected for hepatitis B surface antigen (HBsAg) positivity correlation between serum anti-BKV IgG optical density and negativity. (cdc.gov)
  • Testing for Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies was performed at initiation of dialysis and every 3-6 months thereafter. (biomedcentral.com)
  • Enzyme-linked immune sorbent assay test (ELISA) was used to detect hepatitis B surface antigen (HBsAg) in serum. (archive.org)
  • This crosslsectional study was conducted antigen (HBsAg) positive [ 3 ]. (who.int)
  • No se detectó HBsAg, pero se detectó el reactivo anti-HBc total aislado en el 1,6% de los individuos. (bvsalud.org)
  • The 2010 targets of the China Hepatitis B Prevention Programme were a prevalence of hepatitis B surface antigen (HBsAg) less than 1.0% for children less than five years old and less than 6.0% for the total population. (who.int)
  • Description: The nucleocapsid of hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. (essentialbiosafety.info)
  • The vaccine is derived from hepatitis B surface antigen (HBsAg) produced through recombinant DNA techniques from yeast cells. (medicine.com)
  • The portion of the hepatitis B gene which codes for HBsAg is cloned into yeast which is then cultured to produce hepatitis B vaccine. (medicine.com)
  • In order for it to be displayed on a larger particle, it was inserted into the amino terminus of small hepatitis B surface antigen (HBsAg, S) coding sequence. (asu.edu)
  • An ELISA assay was performed to demonstrate the expression and secretion of HBsAg. (asu.edu)
  • ELISA procedures provide a means for routinely detecting antibodies to specific antigens. (cdc.gov)
  • 4. Kala M, Bajaj K, Sinha S. Magnetic bead enzyme-linked immunosorbent assay (ELISA) detects antigenspecific binding by phage-displayed scFv antibodies that are not detected with conventional ELISA. (interchim.com)
  • Measurement of e-antigen is used to monitor the effectiveness of HBV treatment, where successful treatment will usually elimina te HBeAg from the blood and lead to development of antibodies against e-antigen (anti-HBe). (thenativeantigencompany.com)
  • The major advances in viral respiratory-disease diagnosis include the successful extension of immunofluorescence techniques to more laboratories, use of large-scale production of antibodies in eggs, and development of sensitive solid-phase immunoassays for detection of virus antigens in nasopharyngeal secretions. (cdc.gov)
  • For diarrheal diseases, immunoassays for both rotaviruses and adenoviruses have been further refined and standardized, and monoclonal antibodies have been used in ELISA tests for rotavirus. (cdc.gov)
  • Development of microscopic slides containing stable, inactivated, formalin-fixed antigens for Lassa and Ebola viruses has facilitated the detection of antibodies by immunofluorescence. (cdc.gov)
  • Description: This anti-HBc IgM kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative determination of IgM class antibodies to hepatitis B virus core antigen in human serum or plasma. (fgf-erk.com)
  • No of tumors in the patient is correlated with levels of antibodies signs, symptoms, or routine diagnostic test results were to MCV T antigen ( 12 ), leaving little doubt that MCV is the associated with MCV infection, and no correlation between infectious cause for most but not all MCC tumors. (cdc.gov)
  • The seroprevalence of anti-hepatitis A antibodies (corresponding to the immunization rate) was 100% in Sétif, in people aged between 10 and 14 years in 1986. (bvsalud.org)
  • HBV e-antigen (HBeAg), a clinical marker for disease severity, is a soluble variant of the viral capsid protein. (nih.gov)
  • Hepatitis B e antigen (HBeAg) is a marker of wild-type hepatitis B virus replication. (preprints.org)
  • The HBeAg status is employed to evaluate eligibility for antiviral therapy and to prevent the transmission of hepatitis B from mother to child (PMTCT). (preprints.org)
  • Mouse anti HBeAg antibody (M132), specific for Hepatitis B virus e antigen. (thenativeantigencompany.com)
  • Hepatitis B virus E antigen (HBeAg) coated at 0.5µg/ml and 1µg/ml at RT in DPBS for an hour. (thenativeantigencompany.com)
  • precore/core, polymerase (P), envelope (preS1/preS2/S) and X. The precore/core gene is responsible for expression of core protein as well as hepatitis B e antigen (HBeAg), a serological marker of HBV infection correlating with high viral load (Tong et al. (thenativeantigencompany.com)
  • However, there are some types (strains) of HBV that do not make e-antigen, particularly in the Middle East and Asia, where testing for HBeAg is less useful. (thenativeantigencompany.com)
  • The Ortho HBc ELISA Test System is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of total antibody to anti-HBc in human serum or plasma. (cdc.gov)
  • Qualitative determination of the human antibody directed against hepatitis C virus (anti-HCV) in human serum or plasma is measured using direct solid-phase enzyme immunoassay with the anti-HCV screening ELISA. (cdc.gov)
  • Chiron Corporation, Inc.) is an in vitro qualitative enzyme immunoassay for the detection of antibody to hepatitis C virus (anti-HCV) in human serum or plasma. (cdc.gov)
  • The COBAS AMPLICOR HCV MONITOR Test, version 2 0 (v2.0) is an in vitro nucleic acid amplification test for the quantitation of Hepatitis C Virus RNA in human serum or plasma on the COBAS AMPLICOR Analyzer. (cdc.gov)
  • Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. (taq-polymerase-dna.com)
  • Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. (taq-polymerase-dna.com)
  • Description: Quantitative sandwich ELISA for measuring Human Hepatitis B core antigen IgG (HBc-IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. (toll-likereceptors.com)
  • Serum autoantibodies respond not only to tumor‑associated antigens of hepatocellular carcinoma (HCC) but also to those of liver cirrhosis (LC) and chronic hepatitis (CH). The present prospective multi‑institutional study evaluated the diagnostic properties of six autoantibodies in distinguishing HCC from LC and CH. A total of 416 participants were enrolled: 149 With HCC, 76 with LC, 103 with CH and 88 healthy controls. (spandidos-publications.com)
  • Description: The Human SSA Antibody ELISA kit is designed to detect and quantify the level of human SSA Antibody in cell culture supernatant, serum, plasma and tissue. (zebov-detection.com)
  • Description: Quantitative sandwich ELISA for measuring Human Proliferating cell nuclear antigen antibody (PCNA) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. (zebov-detection.com)
  • Diluted patient serum is added to wells and the rubella IgM specific antibody, if present, binds to the antigen. (rapidtest.com)
  • Assay is a chemiluminescent immunoassay for the qualitative detection of total antibody to hepatitis B core antigen in human serum and plasma specimens. (bloodworksnw.org)
  • Assay is qualitative enzyme-linked immunosorbent assay for the detection of total antibody to hepatitis B virus core antigen in human serum or plasma. (bloodworksnw.org)
  • Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse hepatitis B virus surface antibody (HBsAb) in samples from serum, plasma, tissue homogenates and other biological fluids. (essentialbiosafety.info)
  • Calbiotech specializes in immunoassay development and manufacturing, with a comprehensive range of ELISA and CLIA assays for human and animal research, including specific assays for hormone, autoimmune disorders, cancer, infectious diseases and much more. (calbiotech.com)
  • This assay was at least 20-100 times more sensitive in the detection of HBV antigen than conventional enzyme-linked immune-absorbent assays (ELISA). (nih.gov)
  • Clone M132 (MAB12298) is suitable for use as a detection antibody with clone M133 (MAB12299) in ELISA assays. (thenativeantigencompany.com)
  • Postexposure prophylaxis (PEP) with hepatitis A (HepA) vaccine or immune globulin (IG) prevents infection with hepatitis A virus when administered within 2 weeks of exposure. (cdc.gov)
  • NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections. (cdc.gov)
  • Incidence of infection with hepatitis B virus in 56 patients with haemophilia A 1971-1979. (bmj.com)
  • It is intended for use in clinical laboratories for diagnosis and management of patients related to infection with hepatitis B virus. (fgf-erk.com)
  • Mouse anti-Hepatitis B virus E antigen monoclonal IgG2b antibody (clone M132). (thenativeantigencompany.com)
  • Secondly, we produced a hybridoma cell line secreting monoclonal antibody against the core antigen of the hepatitis C virus (HCV) to develop an ELISA kit for the detection of HCV under the guidance of Dr. Rushi Liu and Minjing Liao. (stanford.edu)
  • Description: anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). (fgf-erk.com)
  • Hepatitis A is among the most common vaccine-preventable infections acquired during travel. (cdc.gov)
  • Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. (wikipedia.org)
  • The first hepatitis A vaccine was approved in Europe in 1991, and the United States in 1995. (wikipedia.org)
  • A few formulations combine hepatitis A with either hepatitis B or typhoid vaccine. (wikipedia.org)
  • Soreness or redness where the shot is given, fever, headache, tiredness, or loss of appetite can happen after hepatitis A vaccine. (wikipedia.org)
  • Hepatitis A is the most common vaccine-preventable virus acquired during travel, so people traveling to places where the virus is common like the Indian subcontinent, Africa, Central America, South America, Asia, and Eastern Europe should be vaccinated. (wikipedia.org)
  • Also sold under the brand names HAVpur and VIROHEP-A. This vaccine consists of virosomes, artificial particles composed of synthetic lipids and influenza proteins in addition to the hepatitis A antigen. (wikipedia.org)
  • The Advisory Committee on Immunization Practices (ACIP) Hepatitis Vaccines Work Group conducted a systematic review of the evidence for administering vaccine for PEP to persons aged >40 years and reviewed the HepA vaccine efficacy and safety in infants and the benefits of protection against HAV before international travel. (cdc.gov)
  • PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. (nih.gov)
  • Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis-, hepatitis B-, or poliovirus-containing vaccine, or to any component of PEDIARIX. (nih.gov)
  • TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. (nih.gov)
  • Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any hepatitis A-containing or hepatitis B-containing vaccine, or to any component of TWINRIX, including yeast and neomycin. (nih.gov)
  • In 20.8%, a vaccine response against the hepatitis B virus can be observed. (bvsalud.org)
  • According to the China Children Immunization Programme, a child must be vaccinated with three doses of the hepatitis B vaccine before reaching 12 months of age. (who.int)
  • By 2010, Lianyungang had completed the catch-up immunization of hepatitis B vaccine for children less than 15 years old. (who.int)
  • Hepatitis A vaccine, an inactivated virus vaccine, offers active immunization against hepatitis A virus infection at an effective immune response rate in up to 99% of subjects. (medicine.com)
  • Recombinant hepatitis B vaccine is a noninfectious subunit viral vaccine. (medicine.com)
  • This is comparable to using hepatitis A vaccine and hepatitis B vaccine concomitantly. (medicine.com)
  • Limitations of use: Hepatitis A/hepatitis B vaccine cannot be used for postexposure prophylaxis. (medicine.com)
  • Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. (essentialbiosafety.info)
  • Each adult dose contains 1440 ELISA units of viral antigen adsorbed on aluminium hydroxide (0.5 mg Al). (wikipedia.org)
  • The pediatric (child) doses contain half the amount of viral antigen and aluminium. (wikipedia.org)
  • Viral antigen in the specimen is specifically captured onto the immobilized antibody during specimen incubation. (gentaur.nl)
  • Hepatitis B envelop antigen seroconversion and alanine aminotransferase normalization rates were similar between the groups ( P =0.75 and P =0.36, respectively). (e-cmh.org)
  • Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. (cdc.gov)
  • In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. (cdc.gov)
  • Hepatitis B virus (HBV) is an enveloped double-stranded DNA virus, with a 3.2-kb covalently closed circular DNA, that belongs to the genus O rthohepadnaviruses of the Hepadnaviridae family of viruses. (thenativeantigencompany.com)
  • The e-antigen is found in the blood only when there are viruses also present and is often used as a marker of ability to spread the virus to other people (infectivity). (thenativeantigencompany.com)
  • Hepatitis C and B viruses (HCV and HBV) are leader causes of chronic liver disease worldwide with 170 and 350 million of individuals infected by these viruses, throughout the world, respectively [ 1 , 2 ]. (biomedcentral.com)
  • Variations in the age, sex and race of HCC rates in different geographic regions are likely to be related to differences in the prevalence of hepatitis viruses in the populations, as well as the timing of the spread of the viral infection and the age of individuals at the time of the infection [5] . (madridge.org)
  • Conclusion: The prevalence of infection by the hepatitis B and C viruses is low, although this population is considered to be at high risk for the transmission of these viruses, the majority of those examined reported using only inhalable drugs. (bvsalud.org)
  • This study determined seroprevalence of HBV and hepatitis C virus (HCV) among healthcare workers of Jimma University Medical Center (JUMC). (hindawi.com)
  • In the hepatitis area, advances include growth of hepatitis A virus in tissue-culture systems, use of antigens for IgM immunoassays, the recent production of hepatitis B core antigen from bacteria through genetic engineering, and development of immunoassays for both antigen and antibody associated with the 'delta' antigen. (cdc.gov)
  • HCV core antigen (HCVcAg) testing is a neglected, less expensive and less time consuming test that's presumed to achieve the same aims. (bvsalud.org)
  • and hepatitis B core antibody (total anti-HBc). (who.int)
  • In resource-limited countries where access to enzyme-linked immunosorbent assay (ELISA) remains a challenge, rapid diagnostic tests (RDT) constitute a good alternative. (preprints.org)
  • Enzyme-linked immunosorbent assay (ELISA) for the detection of hepatitis Be antigen and antibody: report of a field trial. (bmj.com)
  • Systematic random sampling technique was used to recruit 240 pregnant women, their data were collected by face to face interview using a pretested questionnaire, while blood sample was collected aseptically to determine hepatitis B surface antigen by enzyme linked immunosorbent assay test kit. (bvsalud.org)
  • Several studies, including those by our research group, have demonstrated potential TAAs in HCC using enzyme-linked immunosorbent assay (ELISA). (spandidos-publications.com)
  • Objective: The research aims to determine the biochemical and serological profile of hepatitis B and C in inmates of a recovery center, Ananindeua, Pará, Brazil. (bvsalud.org)
  • 0.05) in the positivity of HBV detected by ELISA and PCR between study groups. (archive.org)
  • This study reports the prevalence and the viral aspects of HBV infection in HCV-positive patients from Tunisia, a country with intermediate and low endemicity for hepatitis B and C, respectively. (biomedcentral.com)
  • Studying the regulation of signaling reactions of innate immunity by the hepatitis C virus (HCV) will help to reveal the causes of the transition of the acute form of the disease to a chronic course. (crie.ru)
  • The main route of HBV transmission, 2003) on people aged 6 years and over in like hepatitis C virus (HCV) and human iml the city of Nahavand (72 000 population). (who.int)
  • See the commentary-article "Another oral antiviral treatment, but still far away from hepatitis B virus cure" on page 281. (e-cmh.org)
  • Besifovir dipivoxil maleate (BSV), an acyclic nucleotide phosphonate, shows potent antiviral activity against hepatitis B virus. (e-cmh.org)
  • Diagnostic Automation Rubella IgM Elisa Test Kit is intended for use in the detection of IgM antibody to the rubella virus. (rapidtest.com)
  • However, as there is no test method that can offer complete assurance that HIV, Hepatitis B virus or other infectious agents are absent, these reagents should be handled at the Biosafety Level 2, is recommended. (rapidtest.com)
  • Although no test is perfect, hepatitis C testing is an important and accepted method of testing for HCV. (hepatitisprohelp.com)
  • For example, a positive test result for hepatitis C antibody requires confirmation with HCV RNA testing. (hepatitisprohelp.com)
  • The cost of hepatitis C testing depends on the tests that are performed, where the test is conducted, and a patients health insurance coverage. (hepatitisprohelp.com)
  • The SIV p27 Antigen Standard contains sodium azide as a preservative. (gentaur.nl)
  • MCV-seronegative men, 31 subsequently seroconverted over a 4-year follow-up period, corresponding to a 6.6% studies show that MCV T antigen is needed for the tumor annual conversion rate. (cdc.gov)
  • Owing to their enhanced signals, autoantibodies may be more useful as immunodiagnostic markers for cancer detection than tumor-associated antigens (TAAs) ( 7 , 8 ). (spandidos-publications.com)